Although RGD peptides conjugated drug delivery systems aiming at αvβ3 integrin for active tumor targeting therapy have been well documented in several platforms such as liposome22, copolymer23, iron oxide magnetic nanoparticles24, rare studies are focusing on the albumin platform. The gene discussed is ALB; the disease is neoplasm.